MiR-27b-3p Reduces the Efficacy of Propranolol in the Treatment of Infantile Hemangioma by Inhibiting the Expression of Apaf-1
<b>Objective</b>: To explore the role and mechanism of miR-27b-3p in treating infantile hemangiomas (IHs) with propranolol and to clarify the cause of the poor efficacy of propranolol in IHs. <b>Methods</b>: Human umbilical vein endothelial cells (HUVECs) were used as the res...
Saved in:
| Main Authors: | Jing Li, Yifei Zhu, Linyang Xie, Sina Ahmadi, Chonghao Yao, Hao Cui, Xuteng Kang, Junbo Tu, Sijia Na |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/5/1092 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Insights into Risk Factors for Infantile Hemangioma and Propranolol Treatment Outcomes
by: Ioana Roșca, et al.
Published: (2025-07-01) -
Doppler Ultrasound Evaluation of Infantile Hemangiomas Treated with Oral Propranolol Solution: 5 Years of Experience in a Single Institution
by: Ajin Lee, et al.
Published: (2025-04-01) -
Psoriasiform rash possibly induced by oral propranolol in a 12-month-old girl with infantile hemangioma: a case report and literature review
by: Sahar Alruhaimi, et al.
Published: (2025-03-01) -
Treatment With Propranolol for Infantile Hemangioma in 13 Taiwanese Newborns and Young Infants
by: Teng-Chin Hsu, et al.
Published: (2012-04-01) -
Efficacy and safety of propranolol tablets vs. oral solution in neonates with severe infantile hemangiomas: a retrospective study in China
by: Zhiping Wu, et al.
Published: (2025-01-01)